Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Altis Biosystems, Inc. in May, 2022 for $992,302.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44TR004234-01 | Phase II | 992,302 | May 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Altis Biosystems, Inc. in July, 2022 for $256,574.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR004230-01 | Phase I | 256,574 | July 1, 2022 | |||||||
A SBIR Phase II contract was awarded to Altis Biosystems, Inc. in September, 2020 for $712,990.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK121580-02 | Phase II | 712,990 | September 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Altis Biosystems, Inc. in September, 2019 for $747,640.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK117763-02 | Phase II | 747,640 | September 13, 2019 | |||||||
A SBIR Phase I contract was awarded to Altis Biosystems, Inc. in April, 2020 for $245,920.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK125155-01 | Phase I | 245,920 | April 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Altis Biosystems, Inc. in May, 2022 for $293,991.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK130708-01A1 | Phase I | 293,991 | May 9, 2022 | |||||||
A SBIR Phase I contract was awarded to Altis Biosystems, Inc. in September, 2018 for $224,898.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK117763-01A1 | Phase I | 224,898 | September 21, 2018 | |||||||
A SBIR Phase I contract was awarded to Altis Biosystems, Inc. in July, 2021 for $256,543.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK130647-01 | Phase I | 256,543 | July 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Altis Biosystems, Inc. in August, 2019 for $223,049.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK121580-01A1 | Phase I | 223,049 | August 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Altis Biosystems, Inc. in September, 2022 for $988,431.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK130647-02A1 | Phase II | 988,431 | September 30, 2022 | |||||||
A SBIR Phase I contract was awarded to Altis Biosystems, Inc. in September, 2023 for $343,297.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR004549-01A1 | Phase I | 343,297 | September 1, 2023 | |||||||
A SBIR Phase II contract was awarded to Altis Biosystems, Inc. in July, 2023 for $913,659.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44TR004230-02 | Phase II | 913,659 | July 1, 2023 |